1. Home
  2. Labeler Index
  3. Cipla Ltd.
  4. 53104-7514
  5. NDC Package Code: 53104-7514-1 Etoposide

NDC Package 53104-7514-1 Etoposide

Powder - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
53104-7514-1
Package Description:
4 kg in 1 DRUM
Product Code:
53104-7514
Non-Proprietary Name:
Etoposide
Substance Name:
Etoposide
Usage Information:
Etoposide is used to treat testicular cancer and certain forms of lung cancer (such as small cell lung cancer). Etoposide works by slowing the growth of cancer cells.
11-Digit NDC Billing Format:
53104751401
Product Type:
Bulk Ingredient
Labeler Name:
Cipla Ltd.
Dosage Form:
Powder - An intimate mixture of dry, finely divided drugs and/or chemicals that may be intended for internal or external use.
Active Ingredient(s):
  • ETOPOSIDE 4 kg/4kg
    • Sample Package:
    N/A
    Marketing Category:
    BULK INGREDIENT - A category specifying that a product is marketed as a bulk ingredient.
    Start Marketing Date:
    07-13-2018
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Unfinished Product:
    Yes
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 53104-7514-1?

    The NDC Packaged Code 53104-7514-1 is assigned to an UNFINISHED drug package of 4 kg in 1 drum of Etoposide, a bulk ingredient labeled by Cipla Ltd.. The product's dosage form is powder and is administered via form.

    Is NDC 53104-7514 included in the NDC Directory?

    Yes, Etoposide is an UNFINISHED PRODUCT with code 53104-7514 that is active and included in the NDC Directory. The product was first marketed by Cipla Ltd. on July 13, 2018 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 53104-7514-1?

    The 11-digit format is 53104751401. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-153104-7514-15-4-253104-7514-01